Download PDF
Zentralbl Gynakol 2006; 128(4): 196-201
DOI: 10.1055/s-2006-933448
Übersicht

© Georg Thieme Verlag Stuttgart · New York

Ursachen und Therapie von uterinen Blutungsstörungen

Management of Abnormal Uterine BleedingR. Gaetje1 , A. Scharl2 , M. Kaufmann1 , A. Ahr3
  • 1Klinik für Gynäkologie und Geburtshilfe, Johann Wolfgang Goethe-Universität, Frankfurt
  • 2Frauenklinik, Klinikum St. Marien, Amberg
  • 3Gynäkologische Praxis am Ziegelturm, Gelnhausen
Further Information

Publication History

Publication Date:
11 July 2006 (online)

    Permissions and Reprints

Zusammenfassung

Blutungsstörungen gehören zu den häufigsten gynäkologischen Problemen. Die Ursachen von Blutungsstörungen und insbesondere deren Häufigkeit ist abhängig von dem Lebensalter der betroffenen Frau. In der Prä- und Perimenopause sind hormonelle Ursachen mit bis zu 90 % und organische Veränderungen des Uterus wie Myome, Adenomyosis uteri oder Endometriumspolypen mit bis zu 70 % die häufigsten Ursachen. Gerinnungstörungen sind, insbesondere bei jungen Mädchen und Frauen ohne andere erkennbare Ursache, Grund für verstärkte Blutungen. Die Behandlung der Blutungsstörung leitet sich aus der Ursache ab, allerdings führt das therapeutische Ablaufschema, wenn kein Kinderwunsch besteht, in vielen Fällen zu gleichen symptomatischen Maßnahmen. Bei der Behandlung von verstärkten Blutungen werden hauptsächlich folgende Therapieregime eingesetzt, die in der Reihefolge ansteigender Effektivität genannt werden: Gestagen, Östrogen-Gestagen-Kombination, Mirena und Endometriumsablation ggf. Myomenukleation mit vergleichbarer Erfolgsrate und schließlich die Hysterektomie. Die Embolisation der Arteria uterina bei Myomen oder Adenomyosis uteri, nicht-steriodale Antiphlogistika und Antifibrinolytika stellen Alternativen dar, deren Einsatz im Einzelfall sinnvoll sein kann. Die Arbeit gibt einen Überblick über die verschiedenen Ursachen, sinnvolle diagnostische Maßnahmen und Therapiemöglichkeiten von uterinen Blutungssstörungen.

Abstract

Bleeding disorders are one of the most frequent gynecological problems. The causes of bleeding disorders, and their frequency in particular, vary depending on the age of the woman affected. In premenopause and perimenopause, the most frequent causes are hormonal, in up to 90 % of cases, as well as organic changes in the uterus such as myomas, adenomyosis uteri, or endometrial polyps, in up to 70 % of cases. Coagulation defects cause increased bleeding, particularly in girls and young women, with no other recognizable cause. The treatment of bleeding disorders is causally based, although if the woman does not wish to have children, the therapeutic algorithm in many cases leads to similar symptomatic measures. The following therapeutic approaches, listed in order of increasing efficacy, are mainly used in the treatment of increased bleeding: gestagen, estrogen-gestagen combination, levonorgestrel (Mirena®) and endometrial ablation or myoma enucleation, with comparable success rates, and finally hysterectomy. Embolization of the uterine artery in myomas or adenomyosis uteri, nonsteroidal anti-inflammatory drugs, and antifibrinolytic agents represent alternatives that may be useful in individual cases. The paper provides an overview of the various causes, useful diagnostic measures, and treatment options in uterine bleeding disorders.

Schlüsselwörter

Menorrhagie - Endometriumsablation - Mirena - Myomenukleation - Hysterektomie

Key words

myomectomy - hormones - endometrial ablation - hysterectomy

Literatur

  • 1 Hatasaka H. The Evaluation of abnormal uterine bleeding.  Clin Obstet Gynecol. 2005;  48 258-273
    PubMedSearch in Google Scholar
  • 2 Muzaffar M, Akhtar K A, Yasmin S, Mahmood-Ur-Rehman , Iqbal W, Khan M A. Menstrual irregularities with excessive blodd loss: a clinico-pathological correlation.  J Pak med Assoc. 2005;  55 486-489
    PubMedSearch in Google Scholar
  • 3 Strowitzki T. Praktisches Vorgehen bei gestörter Ovarfunktion und mit ihr assoziierter Phänomene. In: Leidenberger F, Strowitzki T, Ortmann O (Hrsg). Klinische Endokrinologie. Springer, Heidelberg 2005; 559-634
  • 4 Singh R H, Blumenthal P. Hormonal management of abnormal uterine bleeding.  Clin Obstet Gynecol. 2005;  48 337-352
    PubMedSearch in Google Scholar
  • 5 Lethaby A E, Cooke I, Ress M. Progesterone or progesterone-releasing intrauterine systems for heavy menstrual bleeding (Cochrane review). In: The Cochrane Library. Issue 4. ISSN 1464-780X 2005
  • 6 Wildermeersch D, Rowe P J. Assessment of menstrual blood loss in Belgian users of new T-shaped levonorgestrel-releasing intrauterine system.  Contraception. 2005;  71 470-473
    CrossrefPubMedSearch in Google Scholar
  • 7 Kingman C E, Kudir R A, Lee C A, Economides D L. The use of levonorgestrel-relaesing intrauterine system for treatment of menorrhagia in women with inherited bleedung disorders.  BJOG. 2004;  111 1425-1428
    CrossrefPubMedSearch in Google Scholar
  • 8 Mercorio F, De Simone R, Spiezio Sardo A, Cerrota G, Bifulco G, Vanacore F, Nappi C. The effect of a levonorgestrel-releasing intrauterine device in the treatment of myoma-related menorrhagia.  Contraception. 2003;  67 277-280
    CrossrefPubMedSearch in Google Scholar
  • 9 Kuhl H. Pharmocology of estrogens anf progesterones: influence of different routes of administration.  Climacteric. 2005;  8 (Suppl 1) 3-63
    CrossrefPubMedSearch in Google Scholar
  • 10 Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy mentrual bleeding (Cochrane review). In: The Cochrane Library. Issue 4. ISSN 1464-780X 2005
  • 11 Lethaby A, Augood C, Duckitt K. Nonsteroidal anti-inflammytory drugs for heavy menstrual bleeding (Cochrane review). In: The Cochrane Library. Issue 4. ISSN 1464-780X 2005
  • 12 Pelage J P, Jacob D, Fazel A, Namur J, Laurent A, Rymer R, Le Dref O. Midterm results of uterine artery embolization for symptomatic adenomyosis: initial experience.  Radiology. 2005;  234 948-953
    CrossrefPubMedSearch in Google Scholar
  • 13 Kim M D, Won J W, Lee D Y, Ahn C S. Uterine artery embolization for adenomyosis without fibroids.  Clin Radiol. 2004;  59 520-526
    CrossrefPubMedSearch in Google Scholar
  • 14 Bai S W, Jang J B, Lee D Y, Jeong K A, Kim S K, Park K H. Uterine artery embolization for the treatment of uterine leiomyomas.  Yonsei Med J. 2002;  43 346-350
    PubMedSearch in Google Scholar
  • 15 Andersen P E, Lund N, Justesen P, Munk T, Elle B, Floridin C. Uterine artery embolization of symptomatic uterine fibroids.  Acta Radiologica. 2001;  42 234-238
    PubMedSearch in Google Scholar
  • 16 Hutchins F L, Worthington-Kirsch R, Berkowitz R P. Selective uterine artery embolization as primary treatment for symptomativ leiomyomata uteri.  J Am Assoc Gynecol Laparosc. 1999;  6 279-284
    CrossrefPubMedSearch in Google Scholar
  • 17 Goodwin S C, McLucas B, Lee M, Chen G BS, Perrella R, Vedantham S, Muir S, Lai A, Sayre J W, DeLeon M BS. Uterine artery embolization for the treamtent of uterine leiomyomata midterm results.  JVIR. 1999;  10 1159-1165
    PubMedSearch in Google Scholar
  • 18 Siskin G P, Stainken B F, Dowling K, Meo P RN, Ahn J, Dolen E G. Outpatients uterine artery embolization for symptomatic uterine fibroids: experience in 49 patients.  JVIR. 2000;  11 305-311
    CrossrefPubMedSearch in Google Scholar
  • 19 Spies J B, Ascher S A, Roth A R, Kim J, Levy E, Gomez-Jorge J. Uterine Artery Embolization for Leiomyomata.  Obstet Gyn. 2001;  98 29-34
    CrossrefPubMedSearch in Google Scholar
  • 20 Watson G M, Walker W J. Uterine artery embolisation for the treatment of symptomatic fibroids in 114 women: reduction in size of the fibroids and women's views of the sucess of the treatment.  BJOG. 2002;  109 129-135
    PubMedSearch in Google Scholar
  • 21 Meyer W R. Embolization of uterine fibroids. RSNA, Chicago 2001
  • 22 Spies J B, Roth A R, Gonsalves S M, Murphy-Skrzyniarz K M. Ovarian function after uterine artery embolization for leiomyomata: assessment with use of follicle stimulating hormone assay.  JVIR. 2001;  12 437-442
    CrossrefPubMedSearch in Google Scholar
  • 23 ACOG . Uterine artery embolization.  Obstet Gynecol. 2004;  103 403-404
    PubMedSearch in Google Scholar
  • 24 Vashist A, Studd J, Carey A, Burn P. Fatal septicaemia after fibroid embolisation.  Lancet. 1999;  354 307
    PubMedSearch in Google Scholar
  • 25 Lanocita R, Frigerio L F, Patelli G. A fatal complication of percutaneous transcatheder embolization for treatment of uterine fibroids. Society of minimal invasive therapy, Boston, Mass 1999
  • 26 De Blok S, de Vries C, Prinnsen H M, Bkaauwgeers H L, Jorna-Meijer L. Fatal sepsis after uterine artery embolization with microspheres.  J Vasc Interv Radiol. 2003;  14 779-783
    PubMedSearch in Google Scholar
  • 27 Makinen J, Johansson J, Tomas C, Heinonen P H, Laatikainen T, Kauko M, Heikkinen A M, Sjöberg J. Morbidity of 10 110 hysterectomies by type of approach.  Human Reprod. 2001;  16 1473-1478
    CrossrefPubMedSearch in Google Scholar
  • 28 ACOG Committee Opinion . Uterine artery embolizazion.  Obstet Gynecol. 2004;  103 403-404
    PubMedSearch in Google Scholar
  • 29 Goldberg J, Pereira L, Berghella V. Pregnancy after uterine artery embolization.  Obstet Gynecol. 2002;  100 869-872
    CrossrefPubMedSearch in Google Scholar
  • 30 Shirk G J. Minimally invasive surgery for ablation of the endometrium.  Clin Obstet Gynecol. 2005;  48 325-336
    PubMedSearch in Google Scholar
  • 31 Goldfarb H A. Combining myoma coagulation with endometrial ablation/resection reduces subsequent surgery rates.  JSLS. 2001;  5 97-98
    PubMedSearch in Google Scholar
  • 32 Soysal M E, Syosal S K, Vicdan K. Thermal balloon ablation in myoma-induced menorrhagia under local anesthesia.  Gyn Obstet Invest. 2001;  51 128-133
    PubMedSearch in Google Scholar
  • 33 Sowter M C, Lethaby A, Singla A A. Pre-operative endometrial thinning agents bifore endometrial destruction for heavy menstrual bleeding (Cochrane review). In: The Cochrane Library. Issue 4. ISSN 1464-780X 2005
  • 34 Lethaby A, Hockey M, Garry R. Endometrial destruction techniques for heavy menstrual bleeding (Cochrane review). In: The Cochrane Library. Issue 4. ISSN 1464-780X 2005
  • 35 Solnik J M, Guido R S, Sanfilippo J S, Krohn M A. The impact of endometrial ablation technique at a large university women's hospital.  Am J Obstet Gynecol. 2005;  193 98-102
    CrossrefPubMedSearch in Google Scholar
  • 36 Hare A A, Olah K S. Pregnancy following endometrial ablation: a review artiche.  J Obstet Gynecol. 2005;  25 108-114
    CrossrefPubMedSearch in Google Scholar
  • 37 Mukul L V, Linn J G. Pregnancy complicated by uterine synechiae after endometrial ablation.  Obstet Gynecol. 2005;  105 1179-1182
    PubMedSearch in Google Scholar
  • 38 Falcone T, Gustilo-Ashby A M. Minimally invasive surgery for mass lesions.  Clin Obstet Gynecol. 2005;  48 353-360
    PubMedSearch in Google Scholar
  • 39 Marziani R, Mossa B, Ebano V, Perniola G, Melluso J, Napolitano C. Transcervical hysteroscopic myomectomy: long-term effects on abnormal uterine bleeding.  Clin Exp Obstet Gynecol. 2005;  32 23-26
    PubMedSearch in Google Scholar
  • 40 Razavi M K, Hwang G, Jahed A, Modanloo S, Chen B. Abdominal myomectomy versus fibroid embolization in the treatment of symptomatic uterine leiomyomas.  AJR. 2003;  180 1571-1575
    CrossrefPubMedSearch in Google Scholar
  • 41 Buttram V C, Reiter R C. Uterine leiomyomata: etiology, symptomatology, and management.  Fertil Steril. 1981;  36 433-445
    PubMedSearch in Google Scholar
  • 42 Sawin S W, Pilevsky N D, Berlin J A, Barnhart K T. Comparability of perioperative morbidity between abdominal myomectomy and hysterectomy for women with uterine leiomyomas.  Am J Obstet Gynecol. 2000;  183 1448-1455
    CrossrefPubMedSearch in Google Scholar
  • 43 Dubuisson J B, Fauconnier A, Deffarges J V, Norgaard C, Kreiker G, Chapron C. Pregnancy outcome and deliveries following laparoscopic myomectomy.  Hum Reprod. 2000;  15 869-873
    CrossrefPubMedSearch in Google Scholar
  • 44 Propst A M, Liberman R F, Harlow B L, Ginsburg E S. Complications of hysteroscopic surgery: predicting patients at risks.  Obstet Gynecol. 2000;  96 517-520
    CrossrefPubMedSearch in Google Scholar
  • 45 Jansen F W, Vredevoogd C B, Van Ulzen K, Hermans J, Trimbos J B, Trimbos-Kemper T CM. Complications of Hysteroscopy: a prospective, multicenter study.  Obstet Gynecol. 2000;  96 266-270
    CrossrefPubMedSearch in Google Scholar
  • 46 ACOG . Hysteroscopy.  Obstet Gynecol. 2005;  106 439-442
    PubMedSearch in Google Scholar
  • 47 Preutthipan S, Herahatya Y. Hysteroscopic polypectomy in 240 premenopausal and postmenopausal women.  Fertil Steril. 2005;  83 705-509
    CrossrefPubMedSearch in Google Scholar
  • 48 Loffer F D. Improving results of hysteroscopic submucosal myomectomy for menorrhagia by concimitant endometrial ablation.  J Minim Invasive Gynecol. 2005;  12 254-260
    PubMedSearch in Google Scholar
  • 49 Crosignani P G, Vercellini P, Apolone G, De Giorni O, Cortesi I, Meschia M. Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes.  Am J Obstet Gynecol. 1997;  177 95-101
    PubMedSearch in Google Scholar
  • 50 Khastgir G, Studd J. Patient's outlook, experience, and satisfaction with hysterectomy, bilateral oophorectomy, and subsequent continuation of hormone replacement therapy.  Am J Obstet Gynecol. 2000;  183 1427-1433
    CrossrefPubMedSearch in Google Scholar
  • 51 Thakar R, Ayers S, Clarkson P, Stanton S, Manyonda I. Outcomes after total versus subtotal abdominal hysterectomy.  N Engl J Med. 2002;  347 1318-1325
    CrossrefPubMedSearch in Google Scholar
  • 52 Okaro E O, Jones K D, Sutton C. Long term outcome following laparoscopic supracervical hysterectomy.  BJOG. 2001;  108 1017-1020
    CrossrefPubMedSearch in Google Scholar
  • 53 Gaetje R. Organerhaltende Therapiemöglichkeiten beim Uterus myomatosus.  Z Gyn. 2004;  126 119-124
    Thieme ConnectPubMedSearch in Google Scholar
  • 54 Kujovich J L. Von Willebrand disease and menorrhagia; prevalence, diagnosis, and management.  Am J Hematol. 2005;  79 220-228
    CrossrefPubMedSearch in Google Scholar
  • 55 Demers C, Derzko C, David M, Douglas J. Gynaecological and obstetrics management of women with inherited bleeding disorders.  J Obstet Gynaecol. 2005;  27 707-732
    PubMedSearch in Google Scholar
  • 56 Abu J, Davies Q, Ireland D. Should women with postcoital bleeding be referred to colposcopy?.  J Obstet Gynecol. 2006;  26 45-47
    PubMedSearch in Google Scholar
  • 57 Shalina R, Amita S, Neera M A. How alarming is psot-coityl bleeding - a cytologic, colposcopic and histopathologic evaluation.  Gynecol Obstet Invest. 1998;  45 205-208
    CrossrefPubMedSearch in Google Scholar
  • 58 Khattab A F, Ewies A A, Appleby D, Cruickshank D J. The outcome of referral with postcoital bleeding (PCB).  J Obstet Gynecol. 2005;  35 279-282
    PubMedSearch in Google Scholar

PD Dr. R. Gaetje

Klinik für Gynäkologie und Geburtshilfe · Johann Wolfgang Goethe-Universität

Theodor Stern-Kai 7

60596 Frankfurt

Phone: 0 69/63 01 74 38

Fax: 0 69/63 01 70 34

Email: Gaetje@em.uni-frankfurt.de